On Open Lable Study Investigation the Safety and Efficacy of rhPTH (1-84) in Subjects with Hypoparathyroidism

Grants and Contracts Details

StatusFinished
Effective start/end date5/8/184/19/21

Funding

  • Shire Human Genetic Therapies Incorporated: $36,426.00